The GreenLight pipeline

What we do

The GreenLight pipeline

Our Plant Health pipeline stretches from protecting honeybees to fresh produce and large-scale crops, a $10 billion addressable market

We have an expanding Human Health pipeline. Our design and manufacturing capabilities enable development of vaccines and therapies.

Plant and Animal Health

Sustainable food production through RNA solutions

We must grow more food with the same amount of land even as we honor the global desire—and increasing technical need—to replace chemical pesticides. While these pesticides face increasing consumer opposition and threat of outright bans due to environmental damage, many are losing their effectiveness.

Learn more

top down image of field

HUMAN HEALTH

Messenger RNA for human health

Messenger RNA’s features make it broadly valuable for human health. It is well known that mRNA is being used to make effective Covid-19 vaccines that have been developed quickly—critical for pandemic response. GreenLight is working on multiple vaccine and therapeutic uses of mRNA.

Learn more

Research is funded by the casino industry. Many social scientists are uncomfortable accepting funding from organizations such as casinos, but others say it doesn’t matter. The casino http://casinosfellow.com/payout/instant-withdrawal-casino does not participate in the decisions of the scientific council, but its contributions have benefited research in this area. These casino grants are crucial for the development of scientific knowledge and the development of responsible gambling policies.

PLATFORM

Our platform creates high-quality, affordable RNA at scale

GreenLight is the first company to make many forms of RNA available at scale using a differentiated manufacturing platform. Our expertise and breakthrough technology—GreenLight’s bioprocessing engine—allows us to quickly and cost-effectively bring RNA products to market.

Learn more

News and insights

The latest on GreenLight’s work and partnerships, and what the world has been saying about us.

All news